Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05776225 · ClinicalTrials.gov registry record
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
A clinical trial of Pulmonary Hypertension and Interstitial Lung Disease, sponsored by United Therapeutics.
- Recruiting
- Registry status
- 300
- Enrollment target
- 20
- Study locations
NCT05776225 is a study of Pulmonary Hypertension and Interstitial Lung Disease that is actively recruiting participants, run by United Therapeutics. The registered enrollment target is 300 participants, below the 609-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (51% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT05776225, a study of Pulmonary Hypertension and Interstitial Lung Disease, is actively recruiting participants, sponsored by United Therapeutics.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 20
- Study locations
Study Summary
Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD).
Conditions Studied
Interventions
- PROCEDURE Right heart catheterization (RHC)
Study Locations (20)
Florida
- Lakeland Regional Health - Lakeland
- NCH Healthcare System - Naples
- University of South Florida Health - Tampa
- Cleveland Clinic Florida - Weston
Illinois
- Loyola University Chicago - Chicago
- Northwestern University - Chicago
- NorthShore University Health System - Glenview
Georgia
- Emory University Hospital - Atlanta
- Piedmont Healthcare - Austell
Michigan
- University of Michigan Int Med Pulmonary and Critical Care - Ann Arbor
- Mclaren Greater Lansing - Okemos
Arizona
- Pulmonary Associates - Phoenix
Connecticut
- Hartford Hospital - Hartford
Kentucky
- University of Kentucky Medical Center - Lexington
Louisiana
- LSU Health Sciences Center New Orleans - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-08-11 |
| Est. Completion | 2026-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05776225
The ClinicalTrials.gov registry entry for NCT05776225 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (51% lower). The listed sponsor is United Therapeutics, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Right heart catheterization (RHC) is the first listed.
NCT05776225 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Illinois, Georgia.
Frequently Asked Questions
What is clinical trial NCT05776225 about?
NCT05776225 is a clinical study titled "Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection". Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD).
What is the current status of trial NCT05776225?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2023-08-11. Estimated completion is 2026-04.
What conditions does trial NCT05776225 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Interstitial Lung Disease.
What interventions are being tested in trial NCT05776225?
The interventions under investigation include: Right heart catheterization (RHC) (PROCEDURE).
Who is sponsoring clinical trial NCT05776225?
This trial is sponsored by United Therapeutics, which has 63 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05776225 being conducted?
This trial has 20 study locations across Arizona, Connecticut, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
-
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.